Inventor · disambiguated record
Yanqun Shu
Also filed as: SHU YANQUN
4 granted patents·18 pending applications·4 citations·filing 2016–2024
60Inventor score
Top patents by PatentIndex Score
22 records- 0189US11752181B2Compositions and methods of treating Huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2018·Granted Sep 12, 2023·4 cites·21 claims
- 0278US2024285667A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0375US2024226203A9Compositions and methods of treating huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0474US12146150B2Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous deliveryVOYAGER THERAPEUTICS INC·Filed 2022·Granted Nov 19, 2024·0 cites·20 claims
- 0569US2025001012A1Aav capsid variants and uses thereofVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0665US2019365793A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0760US12281321B2Frataxin expression constructs having engineered promoters and methods of use thereofVOYAGER THERAPEUTICS INC·Filed 2019·Granted Apr 22, 2025·0 cites·42 claims
- 0860US2025034559A1Compositions and methods for the treatment of tau-related disordersVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0960US2022096657A1Compositions for the treatment of diseaseVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1059US2025049955A1Compositons and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiencyVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1158US12485188B2Recombinant adeno-associated virus with modified AAV capsid polypeptidesSKYLINE THERAPEUTICS LTD·Filed 2024·Granted Dec 2, 2025·0 cites·20 claims
- 1258US2025011372A1Aav capsid variants and uses thereofVOYAGER THRAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1357US2023285596A1Compositions and methods for the treatment of niemann-pick type c1 diseaseVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1456US2023227802A1Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiencyVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1555US2025369012A1Recombinant aav for the gene therapy of sma diseaseSKYLINE THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1655US2024252686A1Aav for the gene therapy of wet-amdSKYLINE THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1754US2020263199A1Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous deliveryVOYAGER THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1854US2018021364A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1953US2023075314A1VECTORIZED ANTIBODIES (vAb) AND USES THEREOFVOYAGER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2049US2024000971A1Compositions and methods for the treatment of tauopathyVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2143US2022339270A1Compositions and methods for the treatment of tauopathyVOYAGER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2241US2019224339A1Compositions for the treatment of diseaseVOYAGER THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yanqun Shu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →